PSA Today Oct 23: Despite waiting for results, sense of risk on / Eisai, BIIB, Aducanumab / Nidec's revision down / Nissan's new concept EV / W-Scope bounces / Rakuten Mobile connection issues – Nikkei +0.34%
Japan Market Comment by Pelham Smithers, Julie Boote, Joel Scheiman and Thao NguyenNikkei ¥22,625.38 (+¥76.48 / +0.34%); Topix ¥1,638.14 (+¥9.54 / +0.59%); ¥/$108.36
Tags: Eisai (4523 JT), SoftBank Group (9984 JT), WeWork (pvt.), Kitanotatsujin (2930 JT), Tokyo Electron (8035 JT), Texas Instruments (TXN US), Renesas (6723 JT), Kioxia Memory (pvt.), Biogen (BIIB), Nidec (6594 JT), Nissan (7201 JT), Tesla (TSLA US), VW (VOW GR), W-Scope (6619 JT), Rakuten Inc (4755 JT), KDDI (9433 JT)
Main Points
• Risk-on stocks to the fore in mildly positive market
• Does aducanumab do what is wanted?
• Nidec revises down (sort of)
• Nissan presents all-wheel-drive EV concept at Tokyo Motor Show
• W-Scope bounces off recent lows
• Rakuten Mobile faces data connection issues
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.